Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice

Citation
M. Baker et al., Development of T-leukaemias in CD45 tyrosine phosphatase-deficient mutant lck mice, EMBO J, 19(17), 2000, pp. 4644-4654
Citations number
54
Categorie Soggetti
Molecular Biology & Genetics
Journal title
EMBO JOURNAL
ISSN journal
02614189 → ACNP
Volume
19
Issue
17
Year of publication
2000
Pages
4644 - 4654
Database
ISI
SICI code
0261-4189(20000901)19:17<4644:DOTICT>2.0.ZU;2-5
Abstract
The CD45 tyrosine phosphatase lowers T-cell antigen receptor signalling thr esholds by its positive actions on p56(lck) tyrosine kinase function. We no w show that mice expressing active lck(F505) at non-oncogenic levels develo p aggressive thymic lymphomas on a CD45(-/-) background. CD45 suppresses th e tumorigenic potential of the kinase by dephosphorylation of the Tyr394 au tophosphorylation site. In CD45-/- thymocytes the kinase is switched to a h yperactive oncogenic state, resulting in increased resistance to apoptosis, Transformation occurs in early CD4(-)CD8(-) thymocytes during the process of TCR-beta chain rearrangement by a recombinase-independent mechanism. Our findings represent the first example in which a tyrosine phosphatase in si tu prevents the oncogenic actions of a Src family tyrosine kinase.